aprepitant and Sezary-Syndrome

aprepitant has been researched along with Sezary-Syndrome* in 3 studies

Trials

1 trial(s) available for aprepitant and Sezary-Syndrome

Article	Year
Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial. JAMA dermatology, 2018, 10-01, Volume: 154, Issue:10 Topics: Aged; Aprepitant; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurokinin-1 Receptor Antagonists; Pruritus; Sezary Syndrome; Skin Neoplasms; Treatment Failure	2018

Other Studies

2 other study(ies) available for aprepitant and Sezary-Syndrome

Article	Year
Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues. Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:1 Topics: Aprepitant; Chronic Disease; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Pruritus; Sezary Syndrome	2012
Aprepitant as an antipruritic agent? The New England journal of medicine, 2009, Oct-01, Volume: 361, Issue:14 Topics: Antiemetics; Aprepitant; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Pruritus; Sezary Syndrome; Skin Neoplasms	2009